Description: PT Phapros, Tbk, together with its subsidiaries, operates in the pharmaceutical and health care industry in Indonesia. The company operates through Branded / Ethical Prescription Drugs; Over the Counter (OTC) Drugs; Generic Prescription Drugs; and Toll-in Manufacturing segments. It offers OTC drugs, including Antimo Anak, Livron B Plek, Noza, Hemorogard, Bioron, and others. The company also provides generic drug products for government institutions and hospitals, as well as produces drugs for other pharmaceutical industries; and offers medical devices. It exports its products. The company was founded in 1954 and is headquartered in Jakarta, Indonesia. PT Phapros, Tbk is a subsidiary of PT Kimia Farma (Persero) Tbk.
Home Page: www.phapros.co.id
Rajawali Tower 17th Floor
Jakarta,
12950
Indonesia
Phone:
62 21 576 2709
Officers
| Name | Title |
|---|---|
| Mr. Hadi Kardoko | Pres Director |
| Mr. David E. S. Sidjabat | Fin., Risk Management Director & SDM and Director |
| Mr. Erfan Rio Prananto | Gen. Mang. of Accounting |
| Imelda Alini Pohan | Marketing Director & Director |
| Mr. Imam Ariff Juliadi | GM of Gen. Affairs & Asset Management and Acting GM of Human Capital |
| Mr. Riza Effendi | Head of Internal Audit Unit |
| Ida Rahmi Kurniasih | Production Director & Director |
| Ms. Zahmilia Akbar | Corp. Sec. |
Exchange: JK
Country: ID
Currency: Indonesian Rupiah (Rp)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 33.25 |
| Price-to-Book MRQ: | 0.8228 |
| Price-to-Sales TTM: | 0.5066 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1547 |